Rating History for Salix Pharmaceuticals (SLXP) by Brean Capital

More Stocks Rated by Brean Capital | Latest Ratings for SLXP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/8/2013 N/A Maintain Buy
(N/A)		 90.00
(76.00)		  
 		   Details